Lenvatinib With Taxane Drugs Treatment for Advanced Gastric Cancer

Clinical trial NCT05171530 · UNKNOWN

Trial details

NCT number: NCT05171530
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-negative Advanced Gastric Cancer

Start date: 2022-01-05
Primary completion: 2022-12-31
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.